Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59Linda Earnest, Joseph Torresi, Melissa A. Edeling et al.|SSRN Electronic Journal|2024Cited by 0